Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development
复制标题
DOI:
10.1111/j.1440-1827.2010.02526.x
复制
发表时间:
2010-05-01
影响因子:
2.2
通讯作者:
Kuroda, Masahiko
中科院分区:
文献类型:
--
作者:
Shigoka, Masatoshi;Tsuchida, Akihiko;Kuroda, Masahiko
MicroRNAs (miRNAs) belong to a class of the endogenously expressed non-coding small RNAs which primarily function as gene regulators. Growing evidence suggests that miRNAs have a significant role in tumor development and may constitute robust biomarkers for cancer diagnosis and prognosis. The miR-17-92 cluster especially is markedly overexpressed in several cancers, and is associated with the cancer development and progression. In this study, we have demonstrated that miR-92a is highly expressed in hepatocellular carcinoma (HCC). In addition, the proliferation of HCC-derived cell lines was enhanced by miR-92a and inhibited by the anti-miR-92a antagomir. On the other hand, we have found that the relative amount of miR-92a in the plasmas from HCC patients is decreased compared with that from the healthy donors. Interestingly, the amount of miR-92a was elevated after surgical treatment. Thus, although the physiological significance of the decrease of miR-92a in plasma is still unknown, deregulation of miR-92 expression in cells and plasma should be implicated in the development of HCC.